Travere Therapeutics (TVTX) Net Margin Growth (3y) (2017 - 2026)
Travere Therapeutics (TVTX) Net Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | -3,352.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,352.00 |
| Dec 31, 2025 | -7,456.00 |
| Dec 31, 2024 | -5,612.00 |
| Sep 30, 2024 | 5,215.00 |
| Jun 30, 2024 | 7,003.00 |
| Mar 31, 2024 | 11,338.00 |
| Dec 31, 2023 | 23,505.00 |
| Sep 30, 2023 | 69,102.00 |
| Jun 30, 2023 | 10,446.00 |
| Mar 31, 2023 | 3,139.00 |
| Dec 31, 2022 | 13,234.00 |
| Sep 30, 2022 | 13,355.00 |
| Jun 30, 2022 | 13,194.00 |
| Mar 31, 2022 | 12,822.00 |
| Dec 31, 2021 | 7,313.00 |
| Sep 30, 2021 | 8,168.00 |
| Jun 30, 2021 | -1,741.00 |
| Mar 31, 2021 | -6,581.00 |
| Dec 31, 2020 | -19,678.00 |
| Sep 30, 2020 | 2.00 |